The Asia Pacific medical exoskeleton market was valued at US$ 76.43 million in 2023 and is expected to reach US$ 720.20 million by 2031; it is estimated to register a CAGR of 32.4% from 2023 to 2031.
Companies such as Lifeward are focusing on developing exoskeletons that help patients with SCI perform physical activities without pain. For instance, about 20% of the SCI population can be considered candidates for clinical trials of the current ReWalk Personal Exoskeleton or ReWalk Rehabilitation Exoskeleton. Moreover, soft exo-suit devices in medical exoskeletons can be used for patients suffering from SCI. Thus, the increase in the prevalence of SCI and ongoing research for the use of exoskeletons for SCI patients can be expected to fuel the market growth during the forecast period.
By component, the Asia Pacific medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.
In terms of type, the Asia Pacific medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.
Based on extremity, the Asia Pacific medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.
By application, the Asia Pacific medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson’s Disease, and others. The spinal cord injury segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.
In terms of mobility, the Asia Pacific medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.
By end users, the Asia Pacific medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.
Based on country, the Asia Pacific medical exoskeleton market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Japan segment held the largest share of Asia Pacific medical exoskeleton market in 2023.
BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; and Rex Bionics Ltd. are some of the leading companies operating in the Asia Pacific medical exoskeleton market.
Increasing Prevalence of SCI Boosts Asia Pacific Medical Exoskeleton Market
Reduced physical activity and the predominance of seated activities can lead to severe physical and psychological deterioration in people suffering from SCI. Secondary complications related to SCI can also reduce life expectancies. According to the National Library of Medicine, nearly 250,000-500,000 patients suffer from SCIs every year worldwide. An elevated number of cases is attributed to motocross and motorcycling competitions emerging as the most popular sporting activities worldwide, as per the National Institute of Health report. According to the WHO, globally, ~1.19 million people die every year in road crashes, and 20-50 million people suffer non-fatal injuries, with many incurring disabilities.Companies such as Lifeward are focusing on developing exoskeletons that help patients with SCI perform physical activities without pain. For instance, about 20% of the SCI population can be considered candidates for clinical trials of the current ReWalk Personal Exoskeleton or ReWalk Rehabilitation Exoskeleton. Moreover, soft exo-suit devices in medical exoskeletons can be used for patients suffering from SCI. Thus, the increase in the prevalence of SCI and ongoing research for the use of exoskeletons for SCI patients can be expected to fuel the market growth during the forecast period.
Asia Pacific Medical Exoskeleton Market Overview
The medical exoskeleton market in Asia Pacific is sub segmented into Malaysia, Thailand, India, Singapore, the Philippines, Vietnam, Indonesia, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Rising geriatric population, increasing chronic diseases, growing technological advancements, and surging number of startups are the factors favoring the market progress in this region.Asia Pacific Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Medical Exoskeleton Market Segmentation
The Asia Pacific medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.By component, the Asia Pacific medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.
In terms of type, the Asia Pacific medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.
Based on extremity, the Asia Pacific medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.
By application, the Asia Pacific medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson’s Disease, and others. The spinal cord injury segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.
In terms of mobility, the Asia Pacific medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Asia Pacific medical exoskeleton market share in 2023.
By end users, the Asia Pacific medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Asia Pacific medical exoskeleton market share in 2023.
Based on country, the Asia Pacific medical exoskeleton market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Japan segment held the largest share of Asia Pacific medical exoskeleton market in 2023.
BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; and Rex Bionics Ltd. are some of the leading companies operating in the Asia Pacific medical exoskeleton market.
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific medical exoskeleton market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific medical exoskeleton market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific medical exoskeleton market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Medical Exoskeleton Market - Key Market Dynamics
5. Medical Exoskeleton Market - Asia Pacific Analysis
6. Medical Exoskeleton Market Analysis - by Component
7. Medical Exoskeleton Market Analysis - by Type
8. Medical Exoskeleton Market Analysis - by Extremity
9. Medical Exoskeleton Market Analysis - by Application
10. Medical Exoskeleton Market Analysis - by Mobility
11. Medical Exoskeleton Market Analysis - by End Users
12. Asia Pacific Medical Exoskeleton Market - Country Analysis
13. Medical Exoskeleton Market - Industry Landscape
14. Company Profiles
15. Appendix
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Some of the leading companies in the Asia Pacific Medical Exoskeleton Market include:- Ekso Bionics Holdings Inc
- Lifeward, Inc
- ExoAtlet
- Cyberdyne Inc
- BIONIK
- B-Temia Inc
- Hocoma AG
- Myomo Inc
- Rex Bionics Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | February 2025 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value in 2023 | 76.43 Million |
| Forecasted Market Value by 2031 | 720.2 Million |
| Compound Annual Growth Rate | 32.4% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 10 |
